For research use only. Not for therapeutic Use.
NADH-IN-1(Cat No.:I043696)is a small molecule inhibitor designed to modulate the activity of enzymes involved in NADH (nicotinamide adenine dinucleotide) metabolism. By targeting key enzymes in the NADH pathway, this compound can influence cellular processes such as energy production, oxidative stress, and metabolism. NADH-IN-1 is being investigated for its potential therapeutic effects in conditions related to mitochondrial dysfunction, metabolic disorders, and neurodegenerative diseases. Preclinical studies suggest it may play a role in restoring mitochondrial function and improving cellular energy balance, making it a promising candidate for further drug development.
CAS Number | 1432445-15-2 |
Synonyms | 4-thiophen-2-yl-1-[4-[4-(trifluoromethyl)phenyl]piperazin-1-yl]butan-1-one |
Molecular Formula | C19H21F3N2OS |
Purity | ≥95% |
IUPAC Name | 4-thiophen-2-yl-1-[4-[4-(trifluoromethyl)phenyl]piperazin-1-yl]butan-1-one |
InChI | InChI=1S/C19H21F3N2OS/c20-19(21,22)15-6-8-16(9-7-15)23-10-12-24(13-11-23)18(25)5-1-3-17-4-2-14-26-17/h2,4,6-9,14H,1,3,5,10-13H2 |
InChIKey | KJARPKCKZJCRAS-UHFFFAOYSA-N |
SMILES | C1CN(CCN1C2=CC=C(C=C2)C(F)(F)F)C(=O)CCCC3=CC=CS3 |
Chemistry Calculators | Dilution Calculator In vivo Formulation Calculator Molarity Calculator Molecular Weight Calculator Reconstitution Calculator |